newsfilter
← Latest News
GlobeNewswire·

Virios Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

ATLANTA, May 25, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (NASDAQ:VIRI) (the "Company"), a clinical‐stage biopharmaceutical company, today announced that it has regained compliance with the minimum bid price